Guest
Guest
Sep 10, 2025
7:08 AM
|
Vidalista Black 80 mg is a medication combining tadalafil (80 mg), a phosphodiesterase type 5 (PDE5) inhibitor, with dapoxetine (60 mg), a selective serotonin reuptake inhibitor (SSRI). It is designed to treat both erectile dysfunction (ED) and premature ejaculation (PE) simultaneously.
Tadalafil, the active ingredient in Vidalista, was first approved by the U.S. FDA in 2003 under the brand name Cialis, but the combination product VIDALISTA BLACK 80 MG specifically at the 80 mg tadalafil dose, emerged later as pharmaceutical companies developed combination therapies to address both ED and PE in one tablet.
While exact launch dates for Vidalista Black 80 mg are not widely published, it likely entered the market in the mid to late 2010s, following the increasing demand for combination drugs that enhance sexual performance beyond just ED treatment.
The product is primarily manufactured by generic pharmaceutical companies in India, where many combination therapies like Vidalista Black are developed and marketed for both domestic use and export.
If you want the exact introduction date, checking with the manufacturer or official drug regulatory announcements in your country might provide more precise information.
|
